Antigenic shift and increased incidence of meningococcal disease.

BACKGROUND The incidence of serogroup C and Y meningococcal disease increased in the United States during the 1990s. The cyclical nature of endemic meningococcal disease remains unexplained. The purpose of this study was to investigate the mechanisms associated with the increase in the incidence of meningococcal disease. METHODS We characterized an increasing incidence of invasive serogroup C and Y meningococcal disease using population-based surveillance from 1992 through 2001. Isolates were characterized by multilocus sequence typing and antigen sequence typing of 3 outer membrane protein (OMP) genes: porA variable regions (VRs) 1 and 2, porB, and fetA VR. RESULTS For both serogroups, OMP antigenic shifts were associated with increased incidence of meningococcal disease. For serogroup Y, antigenic shift occurred through amino acid substitutions at all 3 OMPs--PorA VR 1 and 2, PorB, and FetA VR. For serogroup C, antigenic shift involved amino acid substitutions at FetA VR and, in some cases, deletion of the porA gene. On the basis of deduced amino acid sequences, the antigenic changes likely occurred by horizontal gene transfer. CONCLUSIONS Antigenic shifts were associated with increased incidence of serogroup C and serogroup Y meningococcal disease. For serogroup Y, the changes involved all OMP genes that were studied. Increases in the incidence of meningococcal disease may be caused, in part, by antigenic shift.

[1]  Martin C. J. Maiden,et al.  mlstdbNet – distributed multi-locus sequence typing (MLST) databases , 2004, BMC Bioinformatics.

[2]  Keith A. Jolley,et al.  PorA Variable Regions of Neisseria meningitidis , 2004, Emerging infectious diseases.

[3]  W. Hanage,et al.  eBURST: Inferring Patterns of Evolutionary Descent among Clusters of Related Bacterial Genotypes from Multilocus Sequence Typing Data , 2004, Journal of bacteriology.

[4]  L. Harrison,et al.  Correlating Epidemiologic Trends with the Genotypes Causing Meningococcal Disease, Maryland , 2004, Emerging infectious diseases.

[5]  L. van Alphen,et al.  Relative Immunogenicity of PorA Subtypes in a Multivalent Neisseria meningitidis Vaccine Is Not Dependent on Presentation Form , 2003, Infection and Immunity.

[6]  Martin C J Maiden,et al.  Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. , 2003, Microbiology.

[7]  Van,et al.  Outbreak of meningococcal disease caused by PorA-deficient meningococci , 2003 .

[8]  J. Wright,et al.  Immunization with the Recombinant PorB Outer Membrane Protein Induces a Bactericidal Immune Response against Neisseria meningitidis , 2002, Infection and Immunity.

[9]  T. Popović,et al.  Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. , 2002, The Journal of infectious diseases.

[10]  L. Harrison,et al.  Cluster of Serogroup C Meningococcal Disease Associated With Attendance at a Party , 2001, Southern medical journal.

[11]  L. Harrison,et al.  Invasive meningococcal disease in adolescents and young adults. , 2001, JAMA.

[12]  T. Popović,et al.  Meningococcal disease. , 2001, The New England journal of medicine.

[13]  L. Harrison,et al.  Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.

[14]  Oleg O. Bilukha,et al.  Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[15]  T. Popović,et al.  Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. , 2000, The Journal of infectious diseases.

[16]  B. Spratt,et al.  Estimating the relative contributions of mutation and recombination to clonal diversification: a comparison between Neisseria meningitidis and Streptococcus pneumoniae. , 2000, Research in microbiology.

[17]  J. Venter,et al.  Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. , 2000, Science.

[18]  S. Salzberg,et al.  Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. , 2000, Science.

[19]  T. Popović,et al.  The changing epidemiology of meningococcal disease in the United States, 1992-1996. , 1999, The Journal of infectious diseases.

[20]  M. Maiden,et al.  Multilocus Sequence Typing and Antigen Gene Sequencing in the Investigation of a Meningococcal Disease Outbreak , 1999, Journal of Clinical Microbiology.

[21]  M. Achtman,et al.  The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis. , 1999, Molecular biology and evolution.

[22]  E. Holmes,et al.  The influence of recombination on the population structure and evolution of the human pathogen Neisseria meningitidis. , 1999, Molecular biology and evolution.

[23]  A. van der Ende,et al.  Deletion of porA by Recombination between Clusters of Repetitive Extragenic Palindromic Sequences in Neisseria meningitidis , 1999, Infection and Immunity.

[24]  L. Harrison,et al.  Risk of meningococcal infection in college students. , 1999, JAMA.

[25]  M. Maiden,et al.  Molecular variation of meningococcal serotype 4 antigen genes , 1998, Epidemiology and Infection.

[26]  M. Maiden,et al.  Amplification of the meningococcal porB gene for non-culture serotype characterization , 1998, Epidemiology and Infection.

[27]  M. Achtman,et al.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Schuchat,et al.  Bacterial Meningitis in the United States in 1995 , 1997 .

[29]  D. Koo,et al.  School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis. , 1997, JAMA.

[30]  P. Cieslak,et al.  Capsule switching of Neisseria meningitidis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Maiden,et al.  Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design , 1996, Clinical and diagnostic laboratory immunology.

[32]  R Staden,et al.  The staden sequence analysis package , 1996, Molecular biotechnology.

[33]  R. May,et al.  The maintenance of strain structure in populations of recombining infectious agents , 1996, Nature Medicine.

[34]  A. Schuchat,et al.  Serogroup C meningococcal outbreaks in the United States. An emerging threat. , 1995, JAMA.

[35]  E. Ford,et al.  Surveillance for diabetes mellitus--United States, 1980-1989; and Laboratory-based surveillance for meningococcal disease in selected areas--United States, 1989-1991 , 1993 .

[36]  M. Achtman,et al.  Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. , 1993, The Journal of infectious diseases.

[37]  P. Moore,et al.  Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  A. Barlow,et al.  Point mutation in meningococcal por A gene associated with increased endemic disease , 1991, The Lancet.

[39]  J. Tommassen,et al.  Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific , 1990, Infection and immunity.

[40]  E. Rosenqvist,et al.  Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. , 1990, Journal of medical microbiology.

[41]  D. Bitter‐Suermann,et al.  An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. , 1987, Journal of immunology.

[42]  J. Gruber.  Bacterial meningitis in the United States, 1978 through 1981: The national bacterial meningitis surveillance study , 1985 .

[43]  M. Leinonen,et al.  ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS Implications for Vaccine Development and Pathogenesis , 1983, The Lancet.

[44]  D. Kasper,et al.  Immunologic response of man to group B meningococcal polysaccharide vaccines. , 1972, The Journal of infectious diseases.